Patents by Inventor Kim D. Janda

Kim D. Janda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100021487
    Abstract: The invention features immunoconjugates for impeding weight gain and treating obesity in a subject. The immuno-conjugates comprise particular ghrelin polypeptides and a suitable carrier moiety.
    Type: Application
    Filed: August 1, 2007
    Publication date: January 28, 2010
    Applicant: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Eric P. Zorrilla, Michael M. Meijler, Kim D. Janda
  • Publication number: 20090117096
    Abstract: This invention generally relates to methods of producing an antibody phage population having affinity for a tumor cell target expressing a metastatic phenotype. The invention further relates to antibody compositions that specifically bind to a cell surface receptor on the metastatic cell.
    Type: Application
    Filed: August 1, 2007
    Publication date: May 7, 2009
    Inventors: Brunhilde Felding-Habermann, Kim D. Janda, Alan Saven
  • Publication number: 20080267981
    Abstract: Methods for treating a neoplastic disease with an antibody-cytotoxin conjugate molecule, methods of synthesizing an antibody-cytotoxin conjugate molecule are provided. Compounds that are useful as antibody-cytotoxin conjugate molecule or useful in the synthesis of these molecules are also provided.
    Type: Application
    Filed: June 29, 2005
    Publication date: October 30, 2008
    Applicant: The Scripps Research Institute
    Inventors: Kim D. Janda, Peter Wirsching, Dale L. Boger
  • Publication number: 20080241943
    Abstract: A fluorescent dye-doped crystalline assay is employed for selection and detection of thiophilic heavy metal ions. While comparable in analytical performance to known solution based methodologies, the formation of crystalline analytes provides for signal amplification, and consequently, a powerful platform whose analysis is directly amenable to high-throughput video capture systems. In a microcapillary format, this assay is capable of screening hundreds of samples per day for the presence of subnanomolar concentrations of Hg2+ using a conventional fluorescence microscope.
    Type: Application
    Filed: November 18, 2005
    Publication date: October 2, 2008
    Applicant: The Scripps Research Institute
    Inventors: Kim D. Janda, Tobin J. Dickerson, James J. La Clair
  • Patent number: 7271245
    Abstract: This invention generally relates to methods of producing an antibody phage population having affinity for a tumor cell target expressing a metastatic phenotype. The invention further relates to antibody compositions that specifically bind to a cell surface receptor on the metastatic cell.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: September 18, 2007
    Assignee: The Scripps Research Institute
    Inventors: Brunhilde Felding-Habermann, Kim D. Janda, Alan Saven
  • Patent number: 7078166
    Abstract: The invention describes the display of exogenous polypeptides on filamentous phage using a fusion between the exogenous polypeptide and phage pVII or pIX proteins. In particular, phage particles and phagemid vectors are described for expression and display of heterodimeric proteins such as antibody Fv heterodimers in combinatorial libraries, and uses thereof.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: July 18, 2006
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Peter Wirsching, Richard A. Lerner, Changshou Gao
  • Patent number: 6849398
    Abstract: A reaction cassette has been designed for the highly sensitive detection of the making and breaking of chemical bonds. The system may be employed as a companion device to be used in the search for antibody and other novel catalysts. The cassette also has important clinical applications in the design of diagnostic reagents. In its fully encoded format this methodology is capable of both detecting and decoding chemical events.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: February 1, 2005
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Richard A. Lerner, Hicham Fenniri
  • Publication number: 20040116350
    Abstract: The invention relates generally to the field of immunology. More specifically, the invention relates the finding that antibodies can generate superoxide and hydrogen peroxide from singlet oxygen. Accordingly, methods and compositions able to increase or decrease oxidative stress are provided. Also provided are screening assays to identify agents that modulate the ability of a antibody to generate superoxide and hydrogen peroxide. Such agents can be used therapeutically to treat patients in need. Further, the invention provides methods to use antibodies in immunoassays.
    Type: Application
    Filed: December 19, 2003
    Publication date: June 17, 2004
    Inventors: Paul Wentworth Jr, Anita D. Wentworth, Lyn H. Jones, Kim D. Janda, Richard A. Lerner
  • Publication number: 20040005649
    Abstract: The present invention provides an anti-stilbene antibody. Preferably, the antibody is a monoclonal antibody. Exemplary and preferred such antibodies are designated herein as 19G2, 20F2, 21C6, 22B9, 25F8, 25E2, 23E4, 23G3, 23D3, 23C2, 25C10, 24B6, 21E2, 16H10 and 9E11. The present invention further provides hybridomas that produce and secrete anti-stilbene antibodies. An antibody of the present invention has particular utility in processes for identifying and/or locating target moieties appended to or incorporating antigenic stilbene. In one embodiment, therefore, the present invention further provides a method of detecting antigenic stilbene. The method includes the steps of exposing antigenic stilbene to an anti-stilbene antibody and detecting an anti-stilbene antibody-stilbene immunoconjugate. Such immunoconjugates can be detected using fluoroscopic procedures.
    Type: Application
    Filed: June 26, 2003
    Publication date: January 8, 2004
    Inventors: Peter Wirsching, Kim D Janda, Richard A. Lerner
  • Patent number: 6664372
    Abstract: Peptidomimetic azatides and combinatorial oligoazitide libraries are produced by means of a stepwise synthesis. Combinatorial library construction of this new biomimetic polymer provides a means to fabricate global peptidomimetic libraries.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: December 16, 2003
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Hyunsoo Han
  • Patent number: 6642035
    Abstract: &bgr;-keto esters are prepared by way of a lipase-catalyzed transesterification. The synthetic methodology provides a simple scheme for the synthesis of optically active &bgr;-keto esters that are useful building blocks and starting materials for natural product synthesis. Moreover, the methodology employs mild, solvent-free conditions. The methodology may also be employed for resolving racemic alcohols.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: November 4, 2003
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Armando Cordova
  • Publication number: 20030186322
    Abstract: The invention describes the display of exogenous polypeptides on filamentous phage using a fusion between the exogenous polypeptide and phage pVII or pIX proteins. In particular, phage particles and phagemid vectors are described for expression and display of heterodimeric proteins such a antibody Fv heterodimers in combinatorial libraries, and uses thereof.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 2, 2003
    Applicant: The Scripps Research Institute
    Inventors: Kim D. Janda, Peter Wirsching, Richard A. Lerner, Changshou Gao
  • Patent number: 6472147
    Abstract: The invention describes the display of exogenous polypeptides on filamentous phage using a fusion between the exogenous polypeptide and phage pVII or pIX proteins. In particular, phage particles and phagemid vectors are described for expression and display of heterodimeric proteins such a antibody Fv heterodimers in combinatorial libraries, and uses thereof.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: October 29, 2002
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Peter Wirsching, Richard A. Lerner, Changshou Gao
  • Publication number: 20020102671
    Abstract: &bgr;-keto esters are prepared by way of a lipase-catalyzed transesterification. The synthetic methodology provides a simple scheme for the synthesis of optically active &bgr;-keto esters that are useful building blocks and starting materials for natural product synthesis. Moreover, the methodology employs mild, solvent-free conditions. The methodology may also be employed for resolving racemic alcohols.
    Type: Application
    Filed: January 26, 2001
    Publication date: August 1, 2002
    Inventors: Kim D. Janda, Armando Cordova
  • Publication number: 20020055124
    Abstract: Polymer supports for liquid-phase organic synthesis (LPOS) are employed in a process for transferring a chemical intermediate between immiscilbe solvents. These compounds are produced with an expanded range of solubility range in a variety of solvent systems. A sequence of normal and “living” free radical polymerizations are employed to generate a library of block copolymers possessing either block or graft architecture with initiators 100, 200 and 3-4 and a diverse set of vinyl monomers 5-9. Novel bifunctional initiators are employed that have functional groups that independently produce free radical polymerizations to produce the block copolymers. Preferred functional groups include diazene (—N═N—) and 2,2,6,6-tetramethylpiperidinyl-1-oxy (TEMPO) moieties tethered by ester or ether linkages.
    Type: Application
    Filed: November 19, 2001
    Publication date: May 9, 2002
    Applicant: The Scripps Research Institute
    Inventors: Kim D. Janda, Dennis J. Gravert
  • Patent number: 6383490
    Abstract: An anti-cocaine vaccine employs a cocaine hapten conjugated to a carrier protein. The anti-cocaine vaccine elicits an immune response which reduces the psychoactive effects of cocaine consumption by the production of anti-cocaine polyclonal antibodies. The antibodies may be employed in an ELISA test for assaying cocaine. The immune response elicited by the anti-cocaine vaccine produces antibody producing cells which may be isolated and cloned for producing anti-cocaine monoclonal antibodies.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: May 7, 2002
    Assignee: The Scripps Research Institute
    Inventors: Peter Wirsching, Kim D. Janda
  • Patent number: 5827827
    Abstract: A series of novel oxirane derivatives, which are useful for inhibiting HIV are disclosed. Particularly of value are peptidomimetic compounds, containing a terminal epoxide group on a peptide or psuedopeptide backbone, which are believed to inhibit HIV protease by extruding enzyme-bound water molecules from the active site of the enzyme.
    Type: Grant
    Filed: June 20, 1996
    Date of Patent: October 27, 1998
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Peter Wirsching
  • Patent number: 5571681
    Abstract: Molecules having covalent catalytic activity are identified by panning synthetic and semisynthetic combinatorial libraries on solid phase suicide substrates. In an alternative mode, mechanism-based inhibitors or affinity labels may substituted for the suicide substrate. Covalent catalysts within the combinatorial library form covalent conjugates with the suicide substrate, mechanism-based inhibitor, or affinity label. Covalent conjugates are immobilized by attachment to the suicide substrate to solid phase and are easily separated from unconjugated elements of the combinatorial library by stringent washing. Combinatorial libraries employing phagemid-display are particularly preferred since such phagemids include genetic material for identifying and amplifying conjugated catalysts. Covalent catalysts obtainable by this method include, inter alia, molecules having esterolytic activity, aldol condensation activity, .beta.-lactamase activity, glycosidase activity, RNase activity, and proteolytic activity.
    Type: Grant
    Filed: March 10, 1994
    Date of Patent: November 5, 1996
    Assignee: The Scripps Research Institute
    Inventor: Kim D. Janda
  • Patent number: 5563121
    Abstract: A peptide linkage unit is employed for joining peptide and pseudopeptide sequences, including peptides and pseudopeptides that inhibit aspartic proteinase enzymes. The peptide linkage unit includes a phosphinate methylene ammonium linkage in place of a peptidyl carboxamide bond. If the peptide linkage unit is incorporated into a peptide sequence that would otherwise serve as an aspartic proteinase substrate and if it is positioned at a cleavage site within such peptide sequence, the phosphinate methylene ammonium linkage is resistant to cleavage and serves as an exploding transition state analog of such cleavage site. When so incorporated, the phosphinate methylene ammonium linkage can bind or interfere with the active site of aspartic proteinase enzymes and inhibit its activity. Preferred inhibitors contain a phosphinic acid methylene amine group joining the P.sub.1 and P.sub.1 ' residues and have a length of 3 to about 15 amino acid residues.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: October 8, 1996
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Peter Wirsching, Shoji Ikeda
  • Patent number: 5559000
    Abstract: A reaction cassette has been designed for the highly sensitive detection of the making and breaking of chemical bonds. The system may be employed as a companion device to be used in the search for antibody and other novel catalysts. The cassette also has important clinical applications in the design of diagnostic reagents. In its fully encoded format this methodology is capable of both detecting and decoding chemical events.
    Type: Grant
    Filed: January 18, 1995
    Date of Patent: September 24, 1996
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Richard A. Lerner, Hicham Fenniri